Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study

Aim: This study aims to perform an external validation of a recently developed prognostic model for early prediction of the risk of progression to severe COVID-19. Patients & methods/materials: Patients were recruited at their initial diagnosis at two facilities within Hamad Medical Corporation...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammedain, Shahd A, Badran, Saif, Elzouki, AbdelNaser Y, Salim, Halla, Chalaby, Ayesha, Siddiqui, MYA, Hussein, Yehia Y, Rahim, Hanan Abdul, Thalib, Lukman, Alam, Mohammed Fasihul, Al-Badriyeh, Daoud, Al-Maadeed, Sumaya, Doi, Suhail AR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630949/
https://www.ncbi.nlm.nih.gov/pubmed/37970094
http://dx.doi.org/10.2217/fvl-2023-0036
Descripción
Sumario:Aim: This study aims to perform an external validation of a recently developed prognostic model for early prediction of the risk of progression to severe COVID-19. Patients & methods/materials: Patients were recruited at their initial diagnosis at two facilities within Hamad Medical Corporation in Qatar. 356 adults were included for analysis. Predictors for progression of COVID-19 were all measured at disease onset and first contact with the health system. Results: The C statistic was 83% (95% CI: 78%–87%) and the calibration plot showed that the model was well-calibrated. Conclusion: The published prognostic model for the progression of COVID-19 infection showed satisfactory discrimination and calibration and the model is easy to apply in clinical practice.d

Ejemplares similares